| Nilam S Ramsinghani, MD | |
|
Uci Medical Center, 101 The City Drive South, Orange, CA 92868 | |
| (714) 456-8978 | |
| Not Available |
| Full Name | Nilam S Ramsinghani |
|---|---|
| Gender | Female |
| Speciality | Radiology - Therapeutic Radiology |
| Location | Uci Medical Center, Orange, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043390289 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0203X | Radiology - Therapeutic Radiology | 000000A37177 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Nilam S Ramsinghani, MD Uci Dept Of Radiation Oncology, Po Box 513286, Los Angeles, CA 90051-3286 Ph: (714) 456-6369 | Nilam S Ramsinghani, MD Uci Medical Center, 101 The City Drive South, Orange, CA 92868 Ph: (714) 456-8978 |
News Archive
Female heart attack patients undergoing angioplasty have a higher risk of death than men, but stenting may improve their outcomes, according to a study reported in Circulation, Journal of the American Heart Association.
Columbia Laboratories, Inc. announced today that the Company has repurchased 1.4 million shares of its common stock, par value $0.01 per share, from Coventry Acquisition, LLC, a subsidiary of Actavis Inc. (Actavis), at $6.08 per share, which represents a 10.75% discount to the closing price on Thursday, March 6, 2014.
Baxter International Inc. today reported first quarter net income of $525 million, an increase of 2 percent from $516 million reported in the first quarter of 2009. Earnings per diluted share of $0.86 increased 4 percent from $0.83 per diluted share reported in the prior-year period. Baxter's first quarter financial results included a one-time, non-cash special charge of $39 million (or $0.07 per diluted share) related to a change in the tax treatment of post-retirement prescription drug benefits under recent U.S. healthcare reform legislation.
Alexion Pharmaceuticals, Inc. today announced financial results for the quarter and year ended December 31, 2010. For the three months ended December 31, 2010, Alexion Pharmaceuticals, Inc. reported net product sales of Soliris® (eculizumab) of $156.0 million, reflecting strong additions of new patients, compared to $110.6 million for the same period in 2009.
› Verified 5 days ago
Dr. Ankit Bhupendra Patel, D.O. Radiology Medicare: Accepting Medicare Assignments Practice Location: 101 The City Dr S, Orange, CA 92868 Phone: 714-456-5113 | |
Kimberly M. Ray, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 431 S Batavia St, Suite 103, Orange, CA 92868 Phone: 714-538-6731 Fax: 714-771-8369 | |
Dr. David Robert Floriolli, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 101 The City Dr S, Orange, CA 92868 Phone: 714-880-7812 | |
Dr. Lawrence C. Wang, DO Radiology Medicare: Medicare Enrolled Practice Location: 101 The City Dr S, Orange, CA 92868 Phone: 714-456-7237 | |
Dr. Akash C. Joshi, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 101 The City Dr S, Orange, CA 92868 Phone: 316-789-5360 | |
Dr. Gerald K. Lee, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 101 The City Dr S, Orange, CA 92868 Phone: 714-456-7237 | |
Dan Vu, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 431 S Batavia St, Ste. 103, Orange, CA 92868 Phone: 714-538-6731 Fax: 714-771-8369 |